Savant Capital, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Savant Capital, LLC
- $17.8 Billion
- Q3 2025
A detailed history of Savant Capital, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 12,721 shares of ARWR stock, worth $524,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,721
Previous 12,695
0.2%
Holding current value
$524,868
Previous $200,000
119.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
341Shares Held
103MCall Options Held
953KPut Options Held
263K-
Vanguard Group Inc Valley Forge, PA16MShares$662 Million0.01% of portfolio
-
Black Rock Inc. New York, NY15.7MShares$647 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.9MShares$450 Million5.14% of portfolio
-
State Street Corp Boston, MA6.4MShares$264 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.98MShares$206 Million3.21% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.37B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...